Premature ovarian failure (POF) in females Amenorrhea before the age of 40, accompanied by elevated FSH levels (FSH>40 U/L), decreased estrogen levels, and other endocrine abnormalities and menopause Form; Refers to premature and complete failure of ovarian function. POF is a highly heterogeneous clinical disease with a mixed etiology. The occurrence of premature ovarian failure is related to abnormalities in granulosa cells, genetic factors, immune factors, mitochondrial dysfunction, environmental factors, and personal habits. The main signs and symptoms of POF include hot flashes, night sweats, facial skin flushing, decreased libido, vaginal dryness, genital atrophy, menstrual irregularities or amenorrhea. May be accompanied by diseases such as osteoporosis and infertility. The clinical treatment of premature ovarian failure often uses artificial cycle therapy with estrogen and progesterone. Although the effect is fast, it is easy to relapse after stopping the medication and requires long-term drug treatment, with significant adverse reactions. In recent years, research has found that traditional Chinese medicine has significant effects in delaying and protecting ovarian function in immune premature ovarian failure. This article explores the etiology, clinical manifestations, pathogenesis, ovarian histological changes, and related treatments of premature ovarian failure.

Subinuer·Maimaiti, Telaitijiang·Tuerxun, Yi Jinling. Research progress in the pathogenesis and treatment of premature ovarian failure. International Journal of Frontiers in Medicine (2023), Vol. 5, Issue 10: 57-61. https://doi.org/10.25236/IJFM.2023.051010.

[1] Nelson L M. Primary ovarian insufficiency [J]. New England Journal of Medicine, 2009, 360(6): 606-614. 

[2] Wang Qingru et al. The repair effect of bone marrow mesenchymal stem cells overexpressing miR-21 on chemotherapy induced premature ovarian failure PLA Medical Journal, 2019 44 (3): Pages 203-209. 

[3] Hoek A, Schoemaker J, Drexhage H A. Premature ovarian failure and ovarian autoimmunity [J]. Endocrine reviews, 1997, 18(1): 107-134. 

[4] Liu W, Nguyen T N, Tran Thi T V, et al. Kuntai capsule plus hormone therapy vs. hormone therapy alone in patients with premature ovarian failure: a systematic review and meta-analysis[J]. Evidence-Based Complementary and Alternative Medicine, 2019. 

[5] Ghahremani‐Nasab M, Ghanbari E, Jahanbani Y, et al. Premature ovarian failure and tissue engineering[J]. Journal of cellular physiology, 2020, 235(5): 4217-4226. 

[6] Hodge A M, Bassett J K, Milne R L, et al. Consumption of sugar-sweetened and artificially sweetened soft drinks and risk of obesity-related cancers[J]. Public health nutrition, 2018, 21(9): 1618-1626. 

[7] Goncalves M D, Lu C, Tutnauer J, et al. High-fructose corn syrup enhances intestinal tumor growth in mice[J]. Science, 2019, 363(6433): 1345-1349. 

[8] Sheikhansari G, Aghebati-Maleki L, Nouri M, et al. Current approaches for the treatment of premature ovarian failure with stem cell therapy[J]. Biomedicine & pharmacotherapy, 2018, 102: 254-262. 

[9] Chen Yue, Chen Si, Zhang Lei, et al. Exploring the Mechanism of Bushen Huoxue Tang in Intervention of Immune Premature Ovarian Failure Mouse Model Based on Estrogen Receptor Pathway [J]. Shaanxi Traditional Chinese Medicine, 2023, 44 (05): 556-561. 

[10] Wang Ke. Study on the Repair Effect of Deer Antler Stem Cells on Cyclophosphamide Induced Premature Ovarian Failure in Rats [D]. Jilin University, 2023. DOI: 10. 27162/d. cnki. gjlin. 2022-007812. 

[11] He Yi. Study on the effect and mechanism of endometrial stem cell extracellular vesicles in the treatment of premature ovarian failure [D]. Liaoning University, 2023. DOI: 10. 27209/d. cnki. glniu. 2022. 001775. 

[12] Rossetti R, Ferrari I, Bonomi M, et al. Genetics of primary ovarian insufficiency [J]. Clin Genet, 2017, 91(2): 183-198. 

[13] Mila M, Alvarez-Mora MI, Madrigal I, et al. Fragile X syndrome: An overview and update of the FMR1 gene [J] . Clin Genet, 2018, 93(2): 197-205. 

[14] Emori C, Ito H, Fujii W, et al. Oocytes suppress FOXL2expression in cumulus cells in mice [ J] . Biol Reprod, 2020, 103(1):85-93. 

[15] Tu Xiaojuan. Preliminary study on Treg regulation of B cell function in immune premature ovarian failure [D]. Chongqing: Chinese People's Liberation Army Military Medical University, 2019. 

[16] Li X, Xie J, Wang Q, et al. miR-21 and pellino - 1 expression profiling in autoimmune premature ovarian insufficiency [J] . J Immunol Res, 2020, 2020: 3582648. 

[17] Zhou Yu, Jia Yuling, Yan Dawei, et al. Comparison of two mouse models of premature ovarian failure [J]. Shanghai Medical Journal, 2018, 41 (8): 489-494. 

[18] Tan R, He Y, Zhang S, et al. Effect of transcutaneous electrical acupoint stimulation on protecting against radiotherapy - induced ovarian damage in mice [J] . J Ovarian Res, 2019, 12(1): 65. 

[19] He Yuheng, Tan Rongrong, Pu Danhua, et al. Radiotherapy induced premature ovarian failure mouse model Construction of type [J]. Journal of Reproductive Medicine, 2017, 26 (12): 1243-1249. 

[20] He Yuheng, Tan Rongrong, Pu Danhua, et al. Construction of a mouse model of radiation induced premature ovarian failure [J]. Journal of Reproductive Medicine, 2017, 26 (12): 1243-1249 DOI: 10. 3969/j. issn. 1004-3845. 2017. 12. 016. 

[21] He Lianli. Preliminary study on the establishment of an animal model of premature ovarian failure induced by D-galactose [J]. Clinical Medical Practice, 2016, 25 (10): 762-764. 

[22] Li Yuanyuan. Construction of an animal model of premature ovarian failure induced by environmental chemical VCD [D]. Shandong: Shandong University, 2010. DOI: 10. 76666/d. Y1792797. 

[23] Xi Hongyan, Zhang Yang, Zhao Xiaoxuan, et al. The latest research progress on the pathological mechanism of premature ovarian failure [J]. Journal of Liaoning University of Traditional Chinese Medicine, 2019, 21 (12): 103-106. DOI: 10. 13194/j. issn. 1673-842x. 2019. 12. 026. 

[24] Liu Min, Wang Jianling, Li Jie. Research progress on the pathogenesis of premature ovarian failure in traditional Chinese and Western medicine [J]. Hunan Journal of Traditional Chinese Medicine, 2015, 31 (09): 178-180. DOI: 10. 16808/j. cnki. issn1003-7705. 2015. 09. 091. 

[25] Kang Yannan, Man Yujing, Leng Yangyang, et al. Exploration of the pathogenesis of premature ovarian failure in traditional Chinese and Western medicine [J]. Guangming Traditional Chinese Medicine, 2015, 30 (02): 358-359. 

[26] Yin N, Wu C, Qiu J, et al. Protective properties of heme oxygenase-1 expressed in umbilical cord mesenchymal stem cells help restore the ovarian function of premature ovarian failure mice through activating the JNK/Bcl-2 signal pathway-regulated autophagy and upregulating the circulating of CD8+ CD28− T cells[J]. Stem Cell Research & Therapy, 2020, 11(1): 1-16. 

[27] Zhu X, Liu J, Pan H, et al. Thymopentin treatment of murine premature ovarian failure via attenuation of immune cell activity and promotion of the BMP4/Smad9 signalling pathway[J]. International Journal of Medical Sciences, 2021, 18(15): 3544. 

[28] Dilinazi Elken, "The effect of traditional Chinese medicine Mu Ni Zi Qi containing serum on cisplatin induced damage to rat ovarian granulosa cells, " 2021, Xinjiang Medical University. 

[29] Li Lingling and Liu Weixia, Effects of Bushen Shugan Formula on Bone Metabolism and Immune Function in Patients with Premature Ovarian Failure New Traditional Chinese Medicine, 2017 49 (09): Pages 81-85. 

[30] Wang Qun and Luo Mingyan, Diagnostic value of peripheral blood macrophage migration inhibitory factor and human leukocyte DR antigen expression in autoimmune premature ovarian failure China Medical Journal, 2021.  18 (27): Pages 93-97. 

[31] Yao Min et al. , Acupuncture treatment for premature ovarian failure and its effect on patient cytokine TNF- α, IFN- γ The impact of expression level China acupuncture and moxibustion, 2019 39 (11): Pages 1181-1184. 

[32] Wang J, Liu C, Fujino M, et al. Stem cells as a resource for treatment of infertility-related diseases[J]. Current molecular medicine, 2019, 19(8): 539-546. 

[33] Zeng Fuling, Clinical Observation on the Treatment of Immune POF and DOR Patients with Huoxue Zishen Formula, 2019, Guangzhou University of Traditional Chinese Medicine. 

[34] Umer A, Khan N, Greene D L, et al. The therapeutic potential of human umbilical cord derived mesenchymal stem cells for the treatment of premature ovarian failure [J]. Stem Cell Reviews and Reports, 2023, 19(3): 651-666. 

[35] Liu X, Song Y, Zhou F, et al. Network and experimental pharmacology on mechanism of Si-Wu-tang improving ovarian function in a mouse model of premature ovarian failure induced by cyclophosphamide [J]. Journal of Ethnopharmacology, 2023, 301: 115842. 

[36] Li Junling, Xie Cuiying, Yu Meijun. The therapeutic effect of Yikun Tongjing Tang combined with Western medicine artificial cycle therapy on premature ovarian failure and its impact on the balance of CD4+CD25+regulatory T cells and Th17 cells in peripheral blood [J]. Chinese Journal of Obstetrics and Gynecology Clinical, 2023, 24 (05): 538-539. DOI: 10. 13390/j. issn. 1672-1861. 2023. 05. 033.